CUChukwuemeka Michael Ubaka

Chukwuemeka Michael Ubaka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chukwuemeka Michael Ubaka has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Patient safety culture in low- and lower-middle-income countries: a systematic review of evidence involving hospital pharmacists

    by Ezinwanne Jane Ugochukwu, Olanrewaju Faith Omotayo, Onyinye Blessing Ukoha-Kalu, Isaac Ibezim, Abdulmuminu Isah, Nneka Uchenna Igboeli, Chukwuemeka Michael Ubaka

    Background: Patient safety culture (PSC) promotes shared values and practices to reduce harm. In low- and lower-middle-income countries (LLMICs), PSC is limited by resources and weak reporting. Hospital pharmacists are key to preventing medication errors and are underrepresented. This review summarizes evidence on their PSC involvement, domain findings, and influencing factors. Methods: We systematically searched PubMed, Web of Science, Scopus, and grey literature (January 2010–December 2025) following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines (PROSPERO: CRD420251125507). Duplicates were removed in Rayyan. Two reviewers independently screened titles/abstracts and full texts against eligibility criteria (hospital pharmacists, PSC assessment, LMIC setting), resolving disagreements by discussion or a third reviewer. Data were extracted using a standardized form (study characteristics, PSC tool, domain scores, predictors, barriers, findings). Quality was appraised with the Joanna Briggs Institute checklist. Findings were narratively synthesized due to heterogeneity; no meta-analysis was performed. Results: From 1350 records identified, 29 studies met the inclusion criteria. All included articles were cross-sectional in design. Most studies were conducted in Africa (22; 75.9%). Only six studies (20.7%) focused exclusively on pharmacists. The Hospital Survey on Patient Safety Culture (HSOPSC) was the most frequently used tool (22; 75.9%). Across studies, teamwork within units was the most consistently high-scoring domain (18; 62.1%). The lowest-scoring domains were staffing and work pace (10; 34.5%) and patient safety incidents, reporting 12 (41.4%). Common barriers identified: blame culture (55.2%), severe staffing shortages (51.7%), and resource constraints (41.4%). Conclusion: Evidence involving hospital pharmacists in LLMICs is limited and largely derived from mixed-profession studies. Teamwork was a relative strength, while staffing and nonpunitive response were recurrent weaknesses, highlighting priorities for strengthening PSC.

  • Open Access

    Stroke Knowledge and Its Determinants Among At-Risk Middle-Aged Adults in a Semi-Urban Nigerian Community

    by Ikeanyi Chinelo Nneka, Odeke Dorathy Akunna, Ugochukwu Ezinwanne Jane, Unyime Eshiet, Isah Abdulmuminu, Ubaka Chukwuemeka Michael

    Background: Stroke is a leading cause of premature mortality and disability in sub-Saharan Africa. Effective prevention depends on timely recognition of stroke symptoms and awareness of its risk factors. This study assessed stroke knowledge and its independent predictors among at-risk middle-aged adults in a semi-urban Nigerian community. Methods: A community-based cross-sectional study was conducted among 316 adults aged 40–65 years using interviewer-administered questionnaires. Stroke knowledge was defined as adequate recognition of both stroke symptoms and risk factors. Pearson’s chi-square test and multivariable binary logistic regression were used to identify independent predictors of combined stroke knowledge. Results: Although 296 (93.7%) respondents were aware of stroke, only 112 (35.4%) demonstrated good combined knowledge of stroke symptoms and risk factors. Sudden weakness of face, arm, or leg was the most correctly identified symptom (78·6%), while sudden visual disturbance (34·1%) and severe headache (37·6%) were poorly recognized. Hypertension was the most identified risk factor (87·6%), but atrial fibrillation (32·9%), alcohol (51·4%), and diabetes (57·0%) were inadequately recognized. Good heart disease knowledge (aOR 3.09, 95% CI 1.82–5.28; p < 0.001) and a previous diagnosis of hypertension (aOR 2.32, 95% CI 1.14–4.71; p = 0.020) were independently associated with good combined stroke knowledge, whereas post-secondary education (aOR 0.37, 95% CI 0.15–0.93; p = 0.034) was inversely associated. Conclusion: Despite high stroke awareness, comprehensive knowledge of stroke symptoms and risk factors remains suboptimal among at-risk middle-aged adults. Integrating stroke education into existing cardiovascular prevention services may provide a practical strategy for improving stroke literacy in high-risk populations.

  • Developing AWaRe-ness in primary care across low- and middle-income countries – a vital challenge for antibiotic stewardship programs

    by Aislinn Cook, Aubrey Chichonyi Kalungia, Chukwuemeka Michael Ubaka, Thuy Thi Phuong Nguyen, Mukhethwa Munzhedzi, Johanna C. Meyer, Salequl Islam, Muhammad Salman, Amanj Kurdi, Stephen M. Campbell, et al.


  • Research productivity and citation impact of Nigerian academic pharmacists: A cross-sectional study

    by Ezinwanne Ugochukwu, Nneka Igboeli, Chukwuemeka Micheal Ubaka

    Background: Research productivity is vital for academic growth and is measured using bibliometrics globally. However, the bibliometric evaluation of academic pharmacy literature in Africa is still developing. This study aimed to evaluate the number and citation impact of publications among Nigerian academic pharmacists and explore their association with sociodemographic characteristics. Methods: A bibliometric analysis was conducted on publications of all academic pharmacists at 21 Faculties of Pharmacy from 2000 to 2019 using Scopus, PubMed, and Google Scholar. Descriptive and inferential statistics were conducted. Results: Among academic pharmacists, 30.5% were female, 24.3% held professorial ranks, and 72% had at least one publication, with 15 authors contributing 25% of all publications. The H-index was higher in Scopus than in Google Scholar, increasing with academic rank (p < 0.05). Both genders produced equal m-quotients in Scopus and Google Scholar. Academics in pharmaceutics had significantly higher productivity and impact in Google Scholar (p < 0.05). South-Eastern pharmacists had the highest mean number of publications, while the North-Eastern region had the lowest percentage (14.3%) of publication-active faculty. Conclusion: Many Nigerian academic pharmacists were not publication-active and had low citation impacts. Research productivity and citation impact were influenced by academic rank, location, and speciality, but not by gender.

  • Open Access

    Study of Glucometer Precision and Antimalarial Therapy Interference on Glucose Readings in Nigeria

    by Ezinwanne Jane Ugochukwu, Adaobi Uchenna Mosanaya, Victor Nnanna Nweze, Marydith Ifeoma Chukwu, Chukwuemeka Michael Ubaka, Mohammed Alawami

    Malaria-infected diabetic (MID) patients have become one of the highest diabetic population with comorbidities in Nigeria. While the artemisinin-based combination therapy (ACT) are used for malaria treatment, glucometers are used to monitor their blood glucose levels. However, some drugs are known to interfere with the accuracy of glucose readings leading to misdiagnosis. In this study, we investigated the interferences of artemether and lumefantrine as well as other known drug interferents on the accuracy of glucose readings in three different glucometers commonly used in Nigeria (Accu-Answer®, VivaChek® and GlucoDr®) . Blood sample was collected from a healthy volunteer, aliquots of the blood with pure samples of artemether and lumefantrinepowders as well as other known drug interferents were prepared in normal and low pools. The precision study on the glucometers were determined. We find that Accu-Answer ® was the only precise glucometer considering its coefficient of variation. The influence of the artemether and lumefantrine was mild in two glucometers andthe predicted binding affinities showed possible binding interactions that may have caused their interferences.

  • Choice of pharmacy, professional perceptions, and career plans of students in three Nigerian schools of pharmacy

    by Abdulmuminu Isah, Adaobi Uchenna Mosanya, Ugonna Augustine Enwereakuh, Hadiza Usman Ma'AJi, Onyinye Blessing Ukoha-Kalu, Isaac Chijioke Ibezim, Chigozie Gloria Anene-Okeke, Chukwuemeka Michael Ubaka

    Background: A progressive increase in the number of students admitted to study pharmacy in Nigeria has not been met with sufficient documented evidence of their preferences and motivations. Studies on this would aid in designing a programme that matches student expectations, whilst maintaining regulatory requirements. Aim: This study evaluated students’ preferences in wanting to study pharmacy, perceptions of the profession and career choice. Method: A cross-sectional questionnaire-based study was conducted among students of all study years across three Nigerian Schools of Pharmacy after obtaining approval from their managements. Data analysis was conducted using descriptive and inferential statistics. Results: The response rate of the study was 87.5%. Most students from the three universities reported a preference for pharmacy as their first choice of course: 733 (86.0%) for University of Nigeria (UNN), 66 (71.7%) for Nnamdi Azikiwe University (NAU) and 48 (45.3%) for Enugu State University of Science and Technology (ESUT). The students’ mean perception of pharmacy was 77.6±13.5%. However, 69.1% (UNN), 64.1% (NAU) and 59.4% (ESUT) students preferred academic pharmacy to other practice areas in pharmacy. Conclusions: Pharmacy was the preferred course of choice for most students currently enrolled in the programme. The students had generally positive perceptions towards the profession.


  • Medication adherence among Nigerian patients with rheumatoid arthritis: a two instruments survey

    by Chukwuemeka M Ubaka, Ozulonye G Ibe, Kosisochi C Amorha, Abdulmuminu Isah, Mathew J Okonta

    Medication adherence is still a significant problem in chronic diseases management and rheumatoid arthritis (RA) is not an exception. There is very little information regarding the level and influencing factors of medication adherence among Nigerian patients with RA. This study evaluated the level and determinants of medication adherence among patients with RA in a Nigerian referral hospital. Using a questionnaire based cross sectional survey, 169 patients with RA were evaluated for their medication adherence using two validated instruments namely; five-item Medication Adherence Report Scale and five-item Compliance Questionnaire for Rheumatology. The two instruments were subjected to descriptive (mean and frequencies) and mean difference (chi-square, t-test, Pearson correlation) analysis, and their reliability (Cronbach alpha) in a Nigerian setting was also established. The level of non-adherence reported in this study was high and ranged from 48.5% for the CQR to 63.9% for the Medication Adherence Report Scale questionnaires respectively. Being of a male gender, of an older age, the higher number of pills taken, better education and the duration of the disease all significantly contributed to higher adherence measures among these RA patients (P <0.05 for all). Both questionnaires used were correlated and reliable for use among patients with rheumatoid arthritis in Nigeria. Findings from this study show that non adherence to medications among RA patients were high and factors such age, gender, education, pill burden could have been responsible.


  • Cost-benefit analysis of prevention of mother-to-child transmission of HIV services: a contingent valuation study of patients’ preferences from clinical pharmacists’ perspective

    by Abdulmuminu Isah, Maxwell Ogochukwu Adibe, Chinwe Victoria Ukwe, Mathew Jegbefume Okonta, Chukwuemeka Michael Ubaka, Deborah Oyine Aluh, Abdulrouf Isah, Hadiza Usman Ma’aJi

    Objectives: Cost-benefit analysis is the least reported economic analysis of prevention of mother-to-child transmission services. In cost-benefit analysis, consumers’ wellbeing is considered from their own perspective. This study determined the benefit-cost ratios of prevention of mother-to-child transmission services in two Nigerian tertiary hospitals. Methods: This was a cross-sectional survey using willingness-to-pay. The study was conducted among patients at Ahmadu Bello University Teaching Hospital and the University of Nigeria Teaching Hospital. Potential benefit was measured as patients’ willingness-to-pay while cost was measured from pharmacists’ perspective. The benefit-cost ratio for each service was obtained as the average after 1000 iterations of Monte Carlo simulation in a probabilistic sensitivity analysis. Key findings: A total of 219 patients responded to the questionnaires. Most of the patients were married, 149 (68.0%). Primary prevention of HIV had the highest ‘yes’ willingness-to-pay response of 152 (69.4%). It also had the highest mean willingness-to-pay amount of N7987.42 ± 4542.00, with willingness-to-pay minimum (maximum) amounts of N100 (N500 000). Primary prevention of HIV had the highest return-on-investment for 15 min of hospital pharmacists’ salary: benefit-cost ratio 19.286 ± 0.170 (95% CI: 18.954 – 19.618). Conclusion: Primary Prevention of HIV had the highest benefit-cost ratio among the six prevention of mother-to-child transmission services. This suggests that healthcare systems will have the highest return-on-investment if they asked patients to pay for the service.


  • Open Access

    Community acceptance and willingness to pay for hypothetical COVID-19 vaccines in a developing country: a web-based nationwide study in Nigeria

    by Ukamaka Gladys Okafor, Abdulmuminu Isah, Jude Chidiebere Onuh, Chiagozie Bonita Mgbemena, Chukwuemeka Michael Ubaka

    INTRODUCTION: Some promising COVID-19 vaccines are soon to be available but getting the African community to accept them may be challenging. This study assessed the acceptability and willingness to pay (WTP) for hypothetical COVID-19 vaccines among Nigerians. METHODS: A cross-sectional, web-based study was conducted among the Nigerian populace. A 20-item questionnaire was used to collect responses through Google form which was shared to consenting participants through two social media platforms. Multivariate logistic regression was used to determine the sociodemographic factors that were predictive of respondents´ willingness to accept the COVID-19 vaccines. Statistical significance was set at p


  • Open Access

    Infrequent Monitoring of the Effects of Valproate and Carbamazepine Therapy in Patients With Epilepsy in Nigeria

    by Unyime Israel Eshiet, Chukwuemeka Michael Ubaka, Chinwe Victoria Ukwe

    Background: Carbamazepine and valproate are widely used in the treatment of epileptic seizures. However, these agents exhibit certain adverse effects including hematopoietic disorders (carbamazepine) and severe hepatotoxicity (valproate).Purpose: To determine the extent of monitoring of the hematologic effects of carbamazepine as well as the extent of monitoring of the hepatic effects of valproate in patients with epilepsy receiving treatment with these agents.Method: A cross-sectional antiepileptic drug use study using case notes of patients with epilepsy managed at the neurologic clinics of 2 tertiary medical facilities in Nigeria between January and December 2017.Results: Carbamazepine was the most frequently prescribed antiepileptic drug (48.24%), followed by valproate (29.34%) and levetiracetam (9.24%). Pretreatment monitoring of hematologic effect was carried out in only 61.11% of patients placed on carbamazepine therapy while follow-up monitoring was done in 3.7% of these patients. Also, in patients placed on valproate therapy, pretreatment and follow-up monitoring of the hepatic effect was done in only 33.71% and 19.0% of the patients, respectively.Conclusions: The extent of monitoring of the hematologic effects of carbamazepine, as well as the hepatic effects of valproate in the cohort studied, is poor.